Announcements

Corvex Management LP filed a Form 144 notice with the SEC on November 10, 2026, disclosing a proposed sale of 375,000 shares of Illumina, Inc. common stock through Goldman Sachs & Co. LLC on the Nasdaq Stock Market.

OPENLANE, Inc. officer Tobin P. Richer filed a Form 144 notice of proposed sale of securities with the U.S. Securities and Exchange Commission on November 10, 2026, covering 3,458 shares of common stock acquired through a stock option exercise.

Thomas D. Lehrman, a former director of Ibotta, Inc., filed a Form 144 notice on November 10, 2026, disclosing a proposed sale of 16,490 shares of Ibotta Class A Common Stock on NYSE:IBTA through J.P. Morgan Securities LLC.

Director Murray B. Low filed a Form 144 notice of proposed sale of 6,537 shares of Trupanion, Inc. common stock, dated November 10, 2026, with the sale to be executed through RBC Capital Markets LLC on NASDAQ.

Snap Inc. officer Ronan Harris filed a Form 144 notice on November 10, 2026, proposing the sale of 100,000 shares of Snap Inc. common stock through Charles Schwab & Co., Inc.

Thomas D. Lehrman, a former director of Ibotta, Inc., filed a Form 144 notice on November 10, 2026, disclosing a proposed sale of 25,570 shares of Ibotta Class A Common Stock through J.P. Morgan Securities LLC on NYSE under ticker NYSE:IBTA.

Bio-Rad Laboratories, Inc. officer Courtney Enloe filed a Form 144 notice on November 10, 2026, disclosing a proposed sale of 902 shares of Bio-Rad common stock on the New York Stock Exchange.